Predictors of Clinical Response to Escitalopram in Obsessive-Compulsive Disorder

Je-Yeon YUN; Min-Soo BYUN; Geumsook SHIM; Hye-Youn PARK; Joon-Hwan JANG; Jae-Yeon HWANG; Sung-Nyun KIM; Jun-Soo KWON.
Korean Journal of Psychopharmacology ; : 214-222, 2011.
Artículo en Ko | WPRIM | ID: wpr-116545

Documentos relacionados

  1. The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine.
  2. Comparable roles for serotonin in rats and humans for computations underlying flexible decision-making.
  3. Severe Urinary Retention Associated With Combined Treatment With Escitalopram and Quetiapine: A Case Report.
  4. Bodily obsessions: intrusiveness of organs in somatic obsessive-compulsive disorder.
  5. Dynamic extracellular vestibule of human SERT: Unveiling druggable potential with high-affinity allosteric inhibitors.
  6. [Pharmacological treatment in early rehabilitation after ischemic stroke].
  7. SSRI antidepressants differentially modulate serotonin reuptake and release in Drosophila.
  8. Escitalopram in the treatment of patients with schizophrenia and obsessive-compulsive disorder: an open-label, prospective study.
  9. Sensing serotonin secreted from human serotonergic neurons using aptamer-modified nanopipettes.
  10. Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study.